This inventor holds 31 USPTO granted patents and 24 published patent applications, plus 3 CIPO patents and 10 EPO patents, primarily in Gene Therapy. Top assignees: The General Hospital Corporation, Children's Medical Center Corporation, Northeastern Ohio University. Active years: 1990-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Newton, MA (US) (1990 - 2024)
- Newton Center, MA (US) (1991 - 2024)
Company Filing History:
24 out of 3,073 
3 out of 1,073 
2 out of 22 
Years Active: 1990-2024
Areas of Expertise:
Title: **The Innovations of Xandra O. Breakefield in Gene Therapy and Muscular Dystrophies**
Introduction
Xandra O. Breakefield is a prominent inventor based in Newton, MA, with a remarkable portfolio of 30 patents to their name. With a focus on groundbreaking medical innovations, Breakefield has made significant contributions to the fields of gene therapy and diagnostics for rare diseases.
Latest Patents
Among their latest inventions is a revolutionary gene therapy targeting tuberous sclerosis complex (TSC). This invention includes compositions and methods that utilize condensed tuberins (cTuberins), as well as recombinant adeno-associated viruses (rAAVs) that carry cTuberin nucleic acids. These innovations are designed to provide effective treatments for patients suffering from TSC. Another significant patent addresses the diagnosis of muscular dystrophies through the identification of extracellular mRNA markers in human urine. This method focuses on detecting correctly and incorrectly spliced isoforms in urine samples, which is pivotal for monitoring diseases related to aberrant splicing.
Career Highlights
Breakefield has played a key role in various prestigious institutions, notably with The General Hospital Corporation and Children's Medical Center Corporation. Their work in these organizations has facilitated advancements in medical research and patient care through innovative therapies.
Collaborations
Throughout their illustrious career, Breakefield has collaborated with notable co-workers such as Johan Karl Olov Skog and E. Antonio Chiocca. Their partnerships underscore the importance of teamwork in driving forward the research and development of critical medical therapies.
Conclusion
Xandra O. Breakefield continues to push the boundaries of medical science with a commitment to developing innovative solutions for complex health issues. With numerous patents and collaborative efforts, Breakefield’s work is poised to have a lasting impact on the fields of gene therapy and diagnostics, giving hope to many patients affected by challenging conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile